J&J's real-world bladder cancer study started in HealthVerity Marketplace
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not just a trend. It is reshaping how life sciences organizations access, manage, and activate real-world data to support everything from R&D to...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
Government health agencies are increasingly turning to real-world data (RWD) for public health...
HealthVerity recently introduced HealthVerity Notes, our newest product designed to unlock the...
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not...
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
Prostate cancer is the most common cancer among men, aside from skin cancer, and is known for being...
FDA's AI guidance is reshaping real-world data standards Artificial Intelligence (AI) is rapidly...
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and analyzed a high-risk non–muscle invasive bladder cancer (HR-NMIBC) population using HealthVerity Marketplace. By using linked, privacy-compliant cla...